AN INVESTIGATION OF DESFERRITHIOCIN METABOLISM

被引:17
作者
BERGERON, RJ
WOLLENWEBER, M
WIEGAND, J
机构
[1] Department of Medicinal Chemistry, University of Florida, Gainesville
关键词
D O I
10.1021/jm00044a009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The hydrolyses of(S)-desferrithiocin (DFT, 1), (R)-desmethyl-DFT (2), and (R)-desazadesmethyl-DFT (3) were studied at pH 2.5 and 7.2 in order to access the stability of the thiazolines at the pH of the stomach and the serum. At 37 degrees C and pH 2.5, DFT (1) (t(1/2) = 18.6 h), desmethyl-DFT (2) (t(1/2) = 8.74 h), and desazadesmethyl-DFT (3) (t(1/2) = 31.7 h) were shown to open principally to the thiol amides with trace amounts of the corresponding thioesters, less than or equal to 2%. The thiazolines were resistant to hydrolysis at pH 7.2. Iron(III) stabilized significantly the thiazolines in the complexes 16a/b of 3 in regard to hydrolysis at pH 2.5 (t(1/2) > 20 days). The iron(III) complexes 16a/b were shown to be stable at pH 7.2. While the thiol amides 13 and 14 of 1 and 2 were isolated from the hydrolysis of the parent desferrithiocins, the thioester 4 and the thiol amide 5 of 3 were. synthesized and their stability in aqueous solution, iron-clearance properties, and toxicity were evaluated. Thioester 4 was shown to rearrange to thiol amide 5 at pH 2.5 and 37 degrees C with a half-life of 4.18 h and instantaneously at pH 7.2. Thiol amide 5 is in equilibrium with 4 (5/4 = 49:1) at pH 2.5 and was shown to be stable at pH 7.2. Thioester 4 and thiol amide 5 demonstrated neither iron-clearance activity in iron-overloaded rats nor toxic side effects in mice. Hydrolysis products of the drug, which might be generated in the stomach, seem unlikely to be the source of the drug's toxicity or iron-clearing properties.
引用
收藏
页码:2889 / 2895
页数:7
相关论文
共 31 条
[21]   HYDROLYSIS OF 2-METHYL-DELTA-2-THIAZOLINE AND ITS FORMATION FROM N-ACETYL-BETA-MERCAPTOETHYLAMINE - OBSERVATIONS ON AN N-S ACYL SHIFT [J].
MARTIN, RB ;
LOWEY, S ;
ELSON, EL ;
EDSALL, JT .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1959, 81 (19) :5089-5095
[22]  
MATZANKE BF, 1989, PHYSICAL BIOORGANIC
[23]  
Modell B, 1979, Prog Hematol, V11, P267
[24]   METABOLITES OF MICROORGANISMS .193. FERRITHIOCIN [J].
NAEGELI, HU ;
ZAHNER, H .
HELVETICA CHIMICA ACTA, 1980, 63 (06) :1400-1406
[25]  
Peter H. H., 1985, PROTEINS IRON STORAG, P293
[26]  
PETER HH, 1985, J PHARMACOL-PARIS, V16, P365
[27]  
RAYMOND KN, 1984, TOP CURR CHEM, V123, P49
[29]   SYNTHESIS OF POLYFUNCTIONAL HYDROXAMIC ACIDS FOR POTENTIAL USE IN IRON CHELATION-THERAPY [J].
VARAPRASAD, DVPR ;
DESARAJU, P ;
WINSTON, A .
BIOORGANIC CHEMISTRY, 1986, 14 (01) :8-16
[30]  
WIELAND T, 1952, LIEBIGS ANN CHEM, V576, P20